Onasemnogene Abeparvovec and Tofacitinib Extended-Release Tablets
Determining the interaction of Onasemnogene Abeparvovec and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Onasemnogene Abeparvovec-Tofacitinib Tablets
- Onasemnogene Abeparvovec-Tofranil
- Onasemnogene Abeparvovec-Tofranil injection
- Onasemnogene Abeparvovec-Tofranil-PM
- Onasemnogene Abeparvovec-Tol-Tab
- Onasemnogene Abeparvovec-Tolazamide
- Tofacitinib Extended-Release Tablets-Onasemnogene abeparvovec Zolgensma
- Tofacitinib Extended-Release Tablets-Oncaspar
- Tofacitinib Extended-Release Tablets-Oncovin
- Tofacitinib Extended-Release Tablets-Ondansetron
- Tofacitinib Extended-Release Tablets-Ondansetron and Dextrose
- Tofacitinib Extended-Release Tablets-Ondansetron Hydrochloride